The US pharmaceutical contract manufacturing is anticipated to grow at a considerable of 4.8% CAGR during the forecast period (2024-2031). The rising investments in R&D is one of the prime factors affecting and driving the market. In the US the spending in R&D is more in pharmaceutical and biotechnology market. The outsourcing of services by companies dealing […]
Tag Archives: US Pharmaceutical Contract Manufacturing Market
The US pharmaceutical contract manufacturing is anticipated to grow at a considerable of 4.8% CAGR during the forecast period (2021-2027). The rising investments in R&D is one of the prime factors affecting and driving the market. In the US the spending in R&D is more in pharmaceutical and biotechnology market. The outsourcing of services by […]